Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis - PubMed (original) (raw)
. 2023 Feb 22;15(684):eabq8476.
doi: 10.1126/scitranslmed.abq8476. Epub 2023 Feb 22.
Tobias V Lanz 1 2 3, Caryn R Hale 4, Gregory D Sepich-Poore 5, Cameron Martino 6 7 8, Austin D Swafford 7, Thomas S Carroll 9, Sarah Kongpachith 1 2, Lisa K Blum 1 2, Serra E Elliott 1 2, Nathalie E Blachere 4 10, Salina Parveen 4, John Fak 4, Vicky Yao 11 12, Olga Troyanskaya 12 13 14, Mayu O Frank 4, Michelle S Bloom 1 2, Shaghayegh Jahanbani 1 2, Alejandro M Gomez 1 2, Radhika Iyer 1 2, Nitya S Ramadoss 1 2, Orr Sharpe 1 2, Sangeetha Chandrasekaran 15, Lindsay B Kelmenson 15, Qian Wang 1 2, Heidi Wong 1 2, Holly L Torres 2, Mark Wiesen 2, Dana T Graves 16, Kevin D Deane 15, V Michael Holers 15, Rob Knight 5 6 7 17, Robert B Darnell 4 10, William H Robinson 1 2, Dana E Orange 4 18
Affiliations
- PMID: 36812347
- PMCID: PMC10496947
- DOI: 10.1126/scitranslmed.abq8476
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis
R Camille Brewer et al. Sci Transl Med. 2023.
Abstract
Periodontal disease is more common in individuals with rheumatoid arthritis (RA) who have detectable anti-citrullinated protein antibodies (ACPAs), implicating oral mucosal inflammation in RA pathogenesis. Here, we performed paired analysis of human and bacterial transcriptomics in longitudinal blood samples from RA patients. We found that patients with RA and periodontal disease experienced repeated oral bacteremias associated with transcriptional signatures of ISG15+HLADRhi and CD48highS100A2pos monocytes, recently identified in inflamed RA synovia and blood of those with RA flares. The oral bacteria observed transiently in blood were broadly citrullinated in the mouth, and their in situ citrullinated epitopes were targeted by extensively somatically hypermutated ACPAs encoded by RA blood plasmablasts. Together, these results suggest that (i) periodontal disease results in repeated breaches of the oral mucosa that release citrullinated oral bacteria into circulation, which (ii) activate inflammatory monocyte subsets that are observed in inflamed RA synovia and blood of RA patients with flares and (iii) activate ACPA B cells, thereby promoting affinity maturation and epitope spreading to citrullinated human antigens.
Conflict of interest statement
Competing interests: W.H.R. is a Founder, member of the Board of Directors, and consultant to Atreca, Inc. D.E.O. and R.B.D. have filed a provisional patent encompassing aspects of this technology. G.D.S-P. is a co-founder of and reports stock interest in Micronoma. The other authors declare that they have no competing interests.
Figures
FIG. 1.. Oral mucosal breaks trigger systemic inflammatory responses.
(A) Experimental workflow. (B) Inferred relative bacterial abundances from eight HMP body sites (_n_=336). (C) Body site inferred relative abundances for timepoints from RA patients with and without periodontal disease, median. (D) Inferred relative oral abundances in blood for one RA donor with and one without periodontal disease. (E) Relative abundances of bacteria genera from oral brushings (left) and blood (right). (F) Log10 adjusted p-values versus log-fold changes of human gene expression relative to bacterial abundances of the three oral body-sites. (G) Enriched GO pathways in differentially expressed human genes from (F) (adjusted p-values). (H) Percent monocytes in blood cell counts compared to inferred relative abundances of oral bacteria, Pearson’s correlation. (I-J) RT-qPCRs of mRNA of inflammatory genes in (I) whole blood, (J) granulocytes, monocytes, lymphocytes (_n_=4–6) stimulated with oral bacteria vs. unstimulated control. (K) Flow cytometry data showing proportion of ISG15+ monocytes in CD14+ monocytes incubated with PBS, oral bacteria, and anti-FcγR2a or isotype (_n_=8). (B), (H), (I), two-tailed Kruskal-Wallis test, Dunnett’s-corrected for multiple comparisons. (C), Mann-Whitney U test. (K), within-subjects ANOVA, Tukey-corrected for multiple comparisons. Mean ± SD *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.001 or exact value shown.
FIG. 2.. Inflammatory synovial monocyte genes are enriched in RA blood during flares and in response to oral bacteremia.
(A) Volcano plot of -log10 adjusted p-value versus log fold change of blood samples in flare versus baseline for RA patients without periodontal disease (left) and RA patients with periodontal disease (right). Colored dots indicate FDR < 0.05. (B) For differentially expressed genes (DEGs) during flares in RA patients with periodontal disease, a scatter-plot showing the direction and value of those DEGs during flares of RA patients with and without periodontal disease. (C) Gene ontology (GO) pathway enrichment analysis of upregulated PD+ specific flare genes and upregulated common flare genes identified in (B). (D) Gene set enrichment analysis (GSEA) results of synovial macrophage clusters for flares in RA patients with periodontal disease (left, red) and flares in RA patients without periodontal disease (left, blue), and oral-derived bacteremias (right). Dashed line indicates FDR of 0.05. (E) PCA biplot of bacteria–human gene expression with co-occurrence probabilities estimated from MMvec. Distances between points quantify the probability of co-occurrence strength between human genes (points). Distances between arrow tips quantify co-occurrence strength between microbes (arrows). Arrow color indicates strength of association of a bacteria with the oral cavity body site.
FIG. 3.. RA antibodies from plasma, synovium, and gingiva bind both citrullinated human and oral bacteria antigens.
(A) Heatmap of normalized mAb reactivity to citrullinated (cit) and native (nat) bacterial lysates and human recombinant proteins as measured by ELISA. Bars below indicate the mutation load in the V-region and predicted N-glycan motifs. (B) SHM frequency in the V-region in ACPA and unreactive mAbs from (A). (C) Quantification of predicted N-linked glycan motifs in ACPA mAbs and unreactive mAbs from (A). (D) Percent inhibition of mAb binding to citrullinated S. parasanguinis and V. parvula bacterial lysates following preincubation with citrullinated or native human proteins. (E) Reactivity of plasma IgG from RA (_n_=33) and healthy controls (_n_=40) against citrullinated and native bacterial lysates. Mean ± SD. (F) Reactivity of synovial fluid IgG from RA (_n_=25) and OA (_n_=25) against citrullinated and native bacterial lysates. Mean ± SD. (G) Cyclic citrullinated peptide (CCP) reactivity of IgG and IgA eluted from oral bacteria from RA patients (_n_=13) and healthy controls (_n_=13). Mean ± SD. For (B), two-tailed student’s t-test was performed. For (C,G), two-tailed Mann-Whitney test was performed. For (D-F), 2-way ANOVA followed by Dunnett’s multiple comparisons test was performed. *P<0.05, **P<0.01, P***<0.001, ****P<0.0001.
FIG. 4.. Commensal bacteria from multiple mucosal sites are citrullinated in vivo.
(A) Single cell bacteria were analyzed by flow cytometry for citrullination and viability determined by SYTOX BC green, propidium iodine, and anti-peptidyl-citrulline antibody staining. (B) Frequency of live citrullinated bacteria sampled from the mouth (_n_=18), stool (_n_=18), and vagina (_n_=11). (C) Relative abundance of the 13 most abundant families in citrullinated (_n_=10, left) and unbound (_n_=10, right) oral sorted fractions. (D) Analysis of composition of microbiomes (ANCOM) of families in citrullinated and unbound sorted oral fractions. (E) Percent of live citrullinated S. parasanguinis after culture with neutrophils (_n=_7) with or without CaCl2. (F) ISG15 expression by flow cytometry of blood monocytes stimulated with citrullinated S. parasanguinis and ACPA mAbs, citrullinated S. parasanguinis and hIgG1 isotype mAb, or PBS (n=10). To produce citrullinated S. parasanguinis, S. parasanguinis was incubated in neutrophil conditioned media with calcium and DTT. Results represent means ± SD. Statistical analysis for (D) was performed using ANCOM. One-way ANOVA followed by Dunnett’s multiple comparisons test and paired t-test was used for statistical analysis for (B) and (E) respectively. Repeated measures one-way ANOVA followed by Tukey’s multiple comparisons test was performed for (F). *P<0.05, **P<0.01, P***<0.001.
FIG. 5.. Identification of citrullinated bacterial epitopes targeted by ACPA.
(A) Mass spectrometry spectra and retention times of citrullinated and native S. parasanguinis amylase peptide from saliva. (B) Reactivity of RA mAbs to citrullinated and native bacterial peptides determined by ELISA. (C) Binding kinetics of RA35 and GLRA35 to citrullinated DnaK (87–106) and citrullinated fibrinogen (556–575). (D) KD values derived from Bio-Layer Interferometry of germline (GL) and ACPA mAbs to citrullinated bacterial and human peptides. (E) Lineage tree analysis of ACPA clonal family as predicted by IgTree. KD values derived from Bio-Layer Interferometry of corresponding mAbs to citrullinated bacterial and human peptides. (F-G) IgG reactivity of (F, left) plasma from RA patients (_n_=46) and healthy patients (_n_=89), (F, right) synovial fluid from RA patients (_n_=31) and OA patients (_n_=34) (right), and (G) plasma from individuals with no or mild periodontal disease (HT, _n_=20), moderate to severe periodontal disease patients (PD, _n_=60), and RA patients with moderate to severe periodontal disease (RA PD, _n_=13) against citrullinated and native AbpA (124–144) by ELISA. Mean ± SD. *P<0.05, **P<0.01, P***<0.001, ****P<0.0001. For (F), 2-way ANOVA followed by Dunnett’s multiple comparisons test was performed. For (G), Kruskal-Wallis test followed by Dunnett’s multiple comparisons test was performed.
Similar articles
- Affinity Maturation Drives Epitope Spreading and Generation of Proinflammatory Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis.
Elliott SE, Kongpachith S, Lingampalli N, Adamska JZ, Cannon BJ, Mao R, Blum LK, Robinson WH. Elliott SE, et al. Arthritis Rheumatol. 2018 Dec;70(12):1946-1958. doi: 10.1002/art.40587. Epub 2018 Oct 20. Arthritis Rheumatol. 2018. PMID: 29927104 Free PMC article. - Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.
Kongpachith S, Lingampalli N, Ju CH, Blum LK, Lu DR, Elliott SE, Mao R, Robinson WH. Kongpachith S, et al. Arthritis Rheumatol. 2019 Apr;71(4):507-517. doi: 10.1002/art.40760. Epub 2019 Feb 27. Arthritis Rheumatol. 2019. PMID: 30811898 Free PMC article. - Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology.
Sherina N, de Vries C, Kharlamova N, Sippl N, Jiang X, Brynedal B, Kindstedt E, Hansson M, Mathsson-Alm L, Israelsson L, Stålesen R, Saevarsdottir S, Holmdahl R, Hensvold A, Johannsen G, Eriksson K, Sallusto F, Catrina AI, Rönnelid J, Grönwall C, Yucel-Lindberg T, Alfredsson L, Klareskog L, Piccoli L, Malmström V, Amara K, Lundberg K. Sherina N, et al. Front Immunol. 2022 Apr 20;13:804822. doi: 10.3389/fimmu.2022.804822. eCollection 2022. Front Immunol. 2022. PMID: 35514991 Free PMC article. - Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis.
Trier NH, Houen G. Trier NH, et al. Expert Rev Mol Diagn. 2023 Jul-Dec;23(10):895-911. doi: 10.1080/14737159.2023.2247986. Epub 2023 Aug 21. Expert Rev Mol Diagn. 2023. PMID: 37578277 Review. - Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD. Sakkas LI, et al. Autoimmun Rev. 2014 Nov;13(11):1114-20. doi: 10.1016/j.autrev.2014.08.012. Epub 2014 Aug 23. Autoimmun Rev. 2014. PMID: 25182207 Review.
Cited by
- Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.
Seefeld ML, Templeton EL, Lehtinen JM, Sinclair N, Yadav D, Hartwell BL. Seefeld ML, et al. Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024. Front Immunol. 2024. PMID: 39286244 Free PMC article. Review. - Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disorders.
Baglaenko Y, Wagner C, Bhoj VG, Brodin P, Gershwin ME, Graham D, Invernizzi P, Kidd KK, Korsunsky I, Levy M, Mammen AL, Nizet V, Ramirez-Valle F, Stites EC, Williams MS, Wilson M, Rose NR, Ladd V, Sirota M. Baglaenko Y, et al. Camb Prism Precis Med. 2023 May 11;1:e25. doi: 10.1017/pcm.2023.14. eCollection 2023. Camb Prism Precis Med. 2023. PMID: 38550937 Free PMC article. Review. - Exploring the In Vitro Antibacterial Potential of Specific Probiotic Strains against Oral Pathogens.
Squarzanti DF, Dell'Atti F, Scalia AC, Najmi Z, Cochis A, Malfa P. Squarzanti DF, et al. Microorganisms. 2024 Feb 21;12(3):441. doi: 10.3390/microorganisms12030441. Microorganisms. 2024. PMID: 38543492 Free PMC article. - Neutrophils in Inflammatory Bone Diseases.
Carmona-Rivera C, Kaplan MJ, O'Neil LJ. Carmona-Rivera C, et al. Curr Osteoporos Rep. 2024 Apr;22(2):280-289. doi: 10.1007/s11914-024-00865-3. Epub 2024 Feb 29. Curr Osteoporos Rep. 2024. PMID: 38418800 Free PMC article. Review. - Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective.
Tanwar H, Gnanasekaran JM, Allison D, Chuang LS, He X, Aimetti M, Baima G, Costalonga M, Cross RK, Sears C, Mehandru S, Cho J, Colombel JF, Raufman JP, Thumbigere-Math V. Tanwar H, et al. J Crohns Colitis. 2024 Aug 14;18(8):1319-1341. doi: 10.1093/ecco-jcc/jjae028. J Crohns Colitis. 2024. PMID: 38417137 Free PMC article. Review.
References
- de Pablo P, Dietrich T, McAlindon TE, Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J. Rheumatol. 35, 70–76 (2008). - PubMed
- Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, CDC Periodontal Disease Surveillance workgroup: James Beck (University of North Carolina, Chapel Hill, USA), Gordon Douglass (Past President, American Academy of Periodontology), Roy Page (University of Washin, Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91, 914–920 (2012). - PubMed
- Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, Markt J, McGowan D, Kerr GS, Redman RS, Reimold A, Griffiths G, Beatty M, Gonzalez SM, Bergman DA, Hamilton BC 3rd, Erickson AR, Sokolove J, Robinson WH, Walker C, Chandad F, O’Dell JR, Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis rheumatol. 66, 1090–1100 (2014). - PMC - PubMed
- Kaneko C, Kobayashi T, Ito S, Sugita N, Murasawa A, Nakazono K, Yoshie H, Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study. PLoS One 13, e0192365 (2018). - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR063676/AR/NIAMS NIH HHS/United States
- T32 AI007290/AI/NIAID NIH HHS/United States
- U01 AI101981/AI/NIAID NIH HHS/United States
- R01 GM071966/GM/NIGMS NIH HHS/United States
- R01 AR078268/AR/NIAMS NIH HHS/United States
- UC2 AR082186/AR/NIAMS NIH HHS/United States
- F30 CA243480/CA/NCI NIH HHS/United States
- U19 AI057229/AI/NIAID NIH HHS/United States
- UL1 TR001866/TR/NCATS NIH HHS/United States
- R35 NS097404/NS/NINDS NIH HHS/United States
- U19 AI110491/AI/NIAID NIH HHS/United States
- T32 AR050942/AR/NIAMS NIH HHS/United States
- P30 AR079369/AR/NIAMS NIH HHS/United States
- T32 HG003284/HG/NHGRI NIH HHS/United States
- T32 GM007198/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous